Search - tctmd.com

Displaying 261 - 280 of 1033

Sort: Relevancy | Date

New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders

News Daily News

New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders

Yael L. Maxwell

March 06, 2020

MODEL U-SES: 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable-Polymer SES

Podcast TCTMD Talking Points

MODEL U-SES: 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable-Polymer SES

March 04, 2020

Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk

News Daily News

Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk

Yael L. Maxwell

March 03, 2020

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

February 28, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

Onyx in hbr-a case based

Presentation JIM 2020

Onyx in hbr-a case based

Presenter: Manoj Kumar

February 14, 2020

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

Presentation JIM 2020

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

Presenter: Marco Valgimigli

February 13, 2020

Ticagrelor Monotherapy Is the Right Choice!

Presentation JIM 2020

Ticagrelor Monotherapy Is the Right Choice!

Presenter: Roxana Mehran

February 12, 2020

Cirrhosis Tied to Poor Outcomes in the Months After PCI

News Daily News

Cirrhosis Tied to Poor Outcomes in the Months After PCI

February 12, 2020

Dual Antiplatelet therapy: How Long to Continue after PC

Presentation BIT 2020

Dual Antiplatelet therapy: How Long to Continue after PC

Presenter: Baren Chakraborty

February 02, 2020

The Cancer Patient Needing PCI Poses Conundrums for Care

News Features

The Cancer Patient Needing PCI Poses Conundrums for Care

January 14, 2020

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

December 10, 2019

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

News Conference News AHA 2019

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Yael L. Maxwell

November 17, 2019

Optimal DAPT Strategies: Lessons Learned, Global Leaders, TWILIGHT, and More

Presentation Controversies and Advances 2019

Optimal DAPT Strategies: Lessons Learned, Global Leaders, TWILIGHT, and More

Presenter: Roxana Mehran

November 15, 2019

Women Bleed More Than Men After PCI, GLOBAL LEADERS Affirms

News Daily News

Women Bleed More Than Men After PCI, GLOBAL LEADERS Affirms

November 07, 2019

DAPT: Hot Topics in 2019

Presentation Cardiovascular Interventions 2019

DAPT: Hot Topics in 2019

Presenter: Dean J. Kereiakes

November 01, 2019

TCTMD’s Top 10 Most Popular Stories for October 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2019

October 31, 2019

Presentation TCT Abstracts Posters 2019

Comparison of Real-World Bleeding and Ischemic Event Rate in P2Y12 Inhibitors After Percutaneous Coronary Intervention: Analysis of Korean National Insurance Claims Data

Presenter: Young-Hyo Lim

October 21, 2019

DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis

News Daily News

DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis

Michael O'Riordan

October 17, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.